α-catulin drives metastasis by activating ILK and driving an αvβ3 integrin signaling axis

Chen Hsien Liang, Szu Ying Chiu, I. Ling Hsu, Yi Ying Wu, Yao Tsung Tsai, Jhen Yu Ke, Szu Hua Pan, Yi Chiung Hsu, Ker Chau Li, Pan Chyr Yang, Yuh-Ling Chen, Tse-Ming Hong

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

α-Catulin is an oncoprotein that helps sustain proliferation by preventing cellular senescence. Here, we report that α-catulin also drives malignant invasion and metastasis. α-Catulin was upregulated in highly invasive non-small cell lung cancer (NSCLC) cell lines, where its ectopic expression or short-hairpin RNA-mediated attenuation enhanced or limited invasion or metastasis, respectively. α-Catulin interacted with integrin-linked kinase (ILK), a serine/threonine protein kinase implicated in cancer cell proliferation, antiapoptosis, invasion, and angiogenesis. Attenuation of ILK or α-catulin reciprocally blocked cell migration and invasion induced by the other protein. Mechanistic investigations revealed that α-catulin activated Akt-NF-κB signaling downstream of ILK, which in turn led to increased expression of fibronectin and integrin αvβ3. Pharmacologic or antibody-mediated blockade of NF-κB or αvβ3 was sufficient to inhibit α-catulin-induced cell migration and invasion. Clinically, high levels of expression of α-catulin and ILK were associated with poor overall survival in patients with NSCLC. Taken together, our study shows that α-catulin plays a critical role in cancer metastasis by activating the ILK-mediated Akt-NF-κB-αvβ3 signaling axis.

Original languageEnglish
Pages (from-to)428-438
Number of pages11
JournalCancer Research
Volume73
Issue number1
DOIs
Publication statusPublished - 2013 Jan 1

Fingerprint

Integrins
Neoplasm Metastasis
Non-Small Cell Lung Carcinoma
Cell Movement
Cell Aging
Protein-Serine-Threonine Kinases
Oncogene Proteins
Fibronectins
Small Interfering RNA
Neoplasms
Cell Proliferation
integrin-linked kinase
Cell Line
Survival
Antibodies
Proteins

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Liang, Chen Hsien ; Chiu, Szu Ying ; Hsu, I. Ling ; Wu, Yi Ying ; Tsai, Yao Tsung ; Ke, Jhen Yu ; Pan, Szu Hua ; Hsu, Yi Chiung ; Li, Ker Chau ; Yang, Pan Chyr ; Chen, Yuh-Ling ; Hong, Tse-Ming. / α-catulin drives metastasis by activating ILK and driving an αvβ3 integrin signaling axis. In: Cancer Research. 2013 ; Vol. 73, No. 1. pp. 428-438.
@article{69f1dadf46aa4397b48b8fb5b8180d17,
title = "α-catulin drives metastasis by activating ILK and driving an αvβ3 integrin signaling axis",
abstract = "α-Catulin is an oncoprotein that helps sustain proliferation by preventing cellular senescence. Here, we report that α-catulin also drives malignant invasion and metastasis. α-Catulin was upregulated in highly invasive non-small cell lung cancer (NSCLC) cell lines, where its ectopic expression or short-hairpin RNA-mediated attenuation enhanced or limited invasion or metastasis, respectively. α-Catulin interacted with integrin-linked kinase (ILK), a serine/threonine protein kinase implicated in cancer cell proliferation, antiapoptosis, invasion, and angiogenesis. Attenuation of ILK or α-catulin reciprocally blocked cell migration and invasion induced by the other protein. Mechanistic investigations revealed that α-catulin activated Akt-NF-κB signaling downstream of ILK, which in turn led to increased expression of fibronectin and integrin αvβ3. Pharmacologic or antibody-mediated blockade of NF-κB or αvβ3 was sufficient to inhibit α-catulin-induced cell migration and invasion. Clinically, high levels of expression of α-catulin and ILK were associated with poor overall survival in patients with NSCLC. Taken together, our study shows that α-catulin plays a critical role in cancer metastasis by activating the ILK-mediated Akt-NF-κB-αvβ3 signaling axis.",
author = "Liang, {Chen Hsien} and Chiu, {Szu Ying} and Hsu, {I. Ling} and Wu, {Yi Ying} and Tsai, {Yao Tsung} and Ke, {Jhen Yu} and Pan, {Szu Hua} and Hsu, {Yi Chiung} and Li, {Ker Chau} and Yang, {Pan Chyr} and Yuh-Ling Chen and Tse-Ming Hong",
year = "2013",
month = "1",
day = "1",
doi = "10.1158/0008-5472.CAN-12-2095",
language = "English",
volume = "73",
pages = "428--438",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "1",

}

Liang, CH, Chiu, SY, Hsu, IL, Wu, YY, Tsai, YT, Ke, JY, Pan, SH, Hsu, YC, Li, KC, Yang, PC, Chen, Y-L & Hong, T-M 2013, 'α-catulin drives metastasis by activating ILK and driving an αvβ3 integrin signaling axis', Cancer Research, vol. 73, no. 1, pp. 428-438. https://doi.org/10.1158/0008-5472.CAN-12-2095

α-catulin drives metastasis by activating ILK and driving an αvβ3 integrin signaling axis. / Liang, Chen Hsien; Chiu, Szu Ying; Hsu, I. Ling; Wu, Yi Ying; Tsai, Yao Tsung; Ke, Jhen Yu; Pan, Szu Hua; Hsu, Yi Chiung; Li, Ker Chau; Yang, Pan Chyr; Chen, Yuh-Ling; Hong, Tse-Ming.

In: Cancer Research, Vol. 73, No. 1, 01.01.2013, p. 428-438.

Research output: Contribution to journalArticle

TY - JOUR

T1 - α-catulin drives metastasis by activating ILK and driving an αvβ3 integrin signaling axis

AU - Liang, Chen Hsien

AU - Chiu, Szu Ying

AU - Hsu, I. Ling

AU - Wu, Yi Ying

AU - Tsai, Yao Tsung

AU - Ke, Jhen Yu

AU - Pan, Szu Hua

AU - Hsu, Yi Chiung

AU - Li, Ker Chau

AU - Yang, Pan Chyr

AU - Chen, Yuh-Ling

AU - Hong, Tse-Ming

PY - 2013/1/1

Y1 - 2013/1/1

N2 - α-Catulin is an oncoprotein that helps sustain proliferation by preventing cellular senescence. Here, we report that α-catulin also drives malignant invasion and metastasis. α-Catulin was upregulated in highly invasive non-small cell lung cancer (NSCLC) cell lines, where its ectopic expression or short-hairpin RNA-mediated attenuation enhanced or limited invasion or metastasis, respectively. α-Catulin interacted with integrin-linked kinase (ILK), a serine/threonine protein kinase implicated in cancer cell proliferation, antiapoptosis, invasion, and angiogenesis. Attenuation of ILK or α-catulin reciprocally blocked cell migration and invasion induced by the other protein. Mechanistic investigations revealed that α-catulin activated Akt-NF-κB signaling downstream of ILK, which in turn led to increased expression of fibronectin and integrin αvβ3. Pharmacologic or antibody-mediated blockade of NF-κB or αvβ3 was sufficient to inhibit α-catulin-induced cell migration and invasion. Clinically, high levels of expression of α-catulin and ILK were associated with poor overall survival in patients with NSCLC. Taken together, our study shows that α-catulin plays a critical role in cancer metastasis by activating the ILK-mediated Akt-NF-κB-αvβ3 signaling axis.

AB - α-Catulin is an oncoprotein that helps sustain proliferation by preventing cellular senescence. Here, we report that α-catulin also drives malignant invasion and metastasis. α-Catulin was upregulated in highly invasive non-small cell lung cancer (NSCLC) cell lines, where its ectopic expression or short-hairpin RNA-mediated attenuation enhanced or limited invasion or metastasis, respectively. α-Catulin interacted with integrin-linked kinase (ILK), a serine/threonine protein kinase implicated in cancer cell proliferation, antiapoptosis, invasion, and angiogenesis. Attenuation of ILK or α-catulin reciprocally blocked cell migration and invasion induced by the other protein. Mechanistic investigations revealed that α-catulin activated Akt-NF-κB signaling downstream of ILK, which in turn led to increased expression of fibronectin and integrin αvβ3. Pharmacologic or antibody-mediated blockade of NF-κB or αvβ3 was sufficient to inhibit α-catulin-induced cell migration and invasion. Clinically, high levels of expression of α-catulin and ILK were associated with poor overall survival in patients with NSCLC. Taken together, our study shows that α-catulin plays a critical role in cancer metastasis by activating the ILK-mediated Akt-NF-κB-αvβ3 signaling axis.

UR - http://www.scopus.com/inward/record.url?scp=84871955157&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871955157&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-12-2095

DO - 10.1158/0008-5472.CAN-12-2095

M3 - Article

VL - 73

SP - 428

EP - 438

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 1

ER -